Quiniodochlor

Quiniodochlor is an antimalarial medication consisting of two active ingredients, chloroquine phosphate and quinine dihydrochloride, designed to target the Plasmodium species that cause malaria. By preventing the parasite from multiplying, it aids in inhibiting the disease’s progression within the host.
Quiniodochlor is primarily indicated for the treatment and prophylaxis of malaria caused by Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. The use of this medication is not recommended for cases involving Plasmodium falciparum, a particularly deadly strain of malaria. Furthermore, healthcare professionals should closely monitor and screen individuals who are at risk or presenting with possible complications.
Certain precautions and considerations apply to the use of Quiniodochlor. The most prominent warning is the risk of prolonged use, as the drug can potentially cause severe eye issues like retinal toxicity. Strict adherence to the dosing and schedule outlined by the healthcare professional should be maintained to minimize potential harm.